Geode Capital Management
EVH icon

Geode Capital Management’s Evolent Health EVH Stock Holding History

Geode Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.97M Sell
2,618,425
-115,019
-4% -$365K ﹤0.01% 2653
2025
Q4 		$10.9M Sell
2,733,444
-23,593
-0.9% -$131K ﹤0.01% 2379
2025
Q3 		$23.3M Buy
2,757,037
+89,395
+3% +$867K ﹤0.01% 1927
2025
Q2 		$30M Buy
2,667,642
+80,155
+3% +$736K ﹤0.01% 1731
2025
Q1 		$24.5M Buy
2,587,487
+73,594
+3% +$743K ﹤0.01% 1793
2024
Q4 		$28.3M Sell
2,513,893
-6,925
-0.3% -$122K ﹤0.01% 1771
2024
Q3 		$71.3M Sell
2,520,818
-80,757
-3% -$2.08M 0.01% 1221
2024
Q2 		$49.8M Buy
2,601,575
+131,713
+5% +$3.36M ﹤0.01% 1364
2024
Q1 		$81M Buy
2,469,862
+104,446
+4% +$3.33M 0.01% 1064
2023
Q4 		$78.1M Buy
2,365,416
+147,967
+7% +$4.19M 0.01% 1022
2023
Q3 		$60.4M Buy
2,217,449
+241,337
+12% +$6.71M 0.01% 1105
2023
Q2 		$59.9M Buy
1,976,112
+352,722
+22% +$11.4M 0.01% 1117
2023
Q1 		$52.7M Buy
1,623,390
+62,313
+4% +$1.97M 0.01% 1145
2022
Q4 		$43.8M Buy
1,561,077
+134,352
+9% +$3.85M 0.01% 1239
2022
Q3 		$51.3M Buy
1,426,725
+35,036
+3% +$1.23M 0.01% 1067
2022
Q2 		$42.7M Sell
1,391,689
-11,896
-0.8% -$347K 0.01% 1234
2022
Q1 		$45.3M Buy
1,403,585
+68,707
+5% +$1.8M 0.01% 1319
2021
Q4 		$36.9M Buy
1,334,878
+18,308
+1% +$525K ﹤0.01% 1531
2021
Q3 		$40.8M Buy
1,316,570
+20,837
+2% +$500K 0.01% 1440
2021
Q2 		$27.4M Buy
1,295,733
+67,520
+5% +$1.35M ﹤0.01% 1760
2021
Q1 		$24.8M Buy
1,228,213
+104,735
+9% +$1.99M ﹤0.01% 1738
2020
Q4 		$18M Buy
1,123,478
+57,756
+5% +$763K ﹤0.01% 1786
2020
Q3 		$13.2M Sell
1,065,722
-39,787
-4% -$468K ﹤0.01% 1790
2020
Q2 		$7.87M Buy
1,105,509
+45,187
+4% +$303K ﹤0.01% 2076
2020
Q1 		$5.76M Buy
1,060,322
+88,468
+9% +$790K ﹤0.01% 2059
2019
Q4 		$8.79M Buy
971,854
+39,313
+4% +$319K ﹤0.01% 2099
2019
Q3 		$6.7M Buy
932,541
+47,761
+5% +$343K ﹤0.01% 2208
2019
Q2 		$7.03M Buy
884,780
+103,979
+13% +$1.23M ﹤0.01% 2170
2019
Q1 		$9.82M Buy
780,801
+41,741
+6% +$661K ﹤0.01% 1903
2018
Q4 		$14.7M Buy
739,060
+70,363
+11% +$1.63M ﹤0.01% 1493
2018
Q3 		$19M Buy
668,697
+60,092
+10% +$1.43M 0.01% 1447
2018
Q2 		$12.8M Buy
608,605
+95,849
+19% +$1.81M ﹤0.01% 1684
2018
Q1 		$7.31M Buy
512,756
+9,341
+2% +$134K ﹤0.01% 1995
2017
Q4 		$6.19M Buy
503,415
+18,461
+4% +$260K ﹤0.01% 2088
2017
Q3 		$8.63M Buy
484,954
+171,430
+55% +$3.53M ﹤0.01% 1832
2017
Q2 		$7.95M Buy
313,524
+183,471
+141% +$4.41M ﹤0.01% 1820
2017
Q1 		$2.9M Buy
130,053
+3,889
+3% +$74.7K ﹤0.01% 2434
2016
Q4 		$1.87M Buy
126,164
+9,352
+8% +$184K ﹤0.01% 2667
2016
Q3 		$2.88M Buy
116,812
+27,622
+31% +$646K ﹤0.01% 2322
2016
Q2 		$1.71M Buy
89,190
+14,105
+19% +$194K ﹤0.01% 2574
2016
Q1 		$792 Buy
75,085
+948
+1% +$9.79K ﹤0.01% 3006
2015
Q4 		$897K Buy
74,137
+23,732
+47% +$350K ﹤0.01% 2966
2015
Q3 		$804K Buy
+50,405
New +$983K ﹤0.01% 2991

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management's EVH Position: Q1 2026 in Review

Geode Capital Management reduced its Evolent Health (EVH) stake by 4.2% in Q1 2026, selling an estimated $365K and leaving 2,618,425 shares worth $5.97M. The position accounts for ﹤0.01% of the portfolio, ranked #2653.

Geode Capital Management first reported a position in EVH in Q3 2015 and has held it in 43 quarters since. The position peaked at $81M in Q1 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Geode Capital Management held 2,618,425 shares of Evolent Health worth $5.97M as of Q1 2026.
  • Geode Capital Management sold 115,019 Evolent Health shares in Q1 2026, an estimated $365K.
  • Evolent Health made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2653 holding.
  • Geode Capital Management first reported a position in Evolent Health in Q3 2015 and has held it in 43 quarters since.
  • Geode Capital Management's Evolent Health position peaked at $81M in Q1 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.